Podcast thumbnail for Investrix and Numerius

Investrix and Numerius

Claim This Podcast

by Investrix and Numerius

13 episodes
Updated Daily
Accepts GuestsHas Sponsors

Podcast Overview

A Gallic merchant walks into a Roman tavern with a stock tip. A Roman accountant reaches for his spectacles. Every week, Investrix and Numerius — one optimist, one skeptic, both armed with real SEC filings and market data — debate a single publicly traded company over amphorae of Falernian wine. The setting is ancient Rome. The analysis is modern. The arguments are genuine. Investrix pitches growth stories with the passion of a man whose last grain cargo arrived mostly sand. Numerius dismantles them with bear-base-bull valuations and the patience of a man with five mouths to feed and exact

Language

🇺🇲

Publishing Since

2/6/2026

Reach the team behind Investrix and Numerius

Verified contact details for this show aren't on file yet — sign up to get notified when they land.

Recent Episodes

Episode thumbnail for Disney (DIS): When Free Cash Flow Falls From $10.1B to $3.75B in One Year

May 14, 2026

Disney (DIS): When Free Cash Flow Falls From $10.1B to $3.75B in One Year

<p>Investrix presents The Walt Disney Company (DIS) as an Empire of Joy — Circi Maximi spread across the world. He defends a Base case of $143/share against the current $108, citing a DTC operating-income swing from near-zero to $1.3 billion in a single year, ROIC tripling from 4.5% to 12.1% in two years, and 710 basis points of operating-margin expansion in four. The cruise fleet is doubling to twelve ships by 2031 — a capital barrier compounding for a decade.</p><p><br>Numerius has concerns. Reported EPS of $6.85 hides a $3.3B Hulu tax benefit; the clean number is $5.93. His owner-earnings DCF lands at $80.60 at 8.25% cost of capital. Trailing free cash flow has collapsed from $10.1B last September to $3.75B today, while guided capex for next year is $9B with a 44% effective tariff on cruise-ship steel. Forty-six dollars and ninety cents of the asking price is being paid for a recomposition not yet on the ledger.</p><p><br>The debate unfolds in a hushed Pythagorean concert hall under the Circus Maximus, the matron behind them shushing every rising whisper. Investrix sees an irreplaceable compounder. Numerius sees a story the chair has not yet cleared — and an FCC pattern that arrived 48 hours after a political demand.<br>Who&#39;s right when the IP fortress is intact but the regulator is the new weight on a known variable?</p><p><br>Topics: DIS stock analysis, Disney valuation, owner-earnings DCF, Disney cruise fleet expansion, FCC license review, Hulu tax benefit, margin recomposition</p>

Episode thumbnail for Boeing (BA): When Your Brother Tells You the Hull Has Finger-Width Gaps

May 9, 2026

Boeing (BA): When Your Brother Tells You the Hull Has Finger-Width Gaps

<p>Investrix presents Boeing (BA) as the comeback story of the decade. Boeingus catapult-house is back: $682 billion in backlog, 600 fuselages delivered last year against 348 the year before, the Spirit AeroSystems wound closed for $4.7 billion in December, the F-47 contract worth more than $20 billion to start, and a Qatar order of roughly $96 billion signed in Doha. </p><p>Gross margin has gone from negative three percent in the trough to 4.8 percent — red to black on the line that matters.<br>Numerius has concerns. The reported $2.48 per share is divestiture-aided, propped up by a $9.5 billion Digital Aviation Solutions sale, while cash burn returned at $1.5 billion in the first quarter alone. Defence is 35 percent of revenue and administration-contingent. The PEG ratio is 4.61. The market is paying for the best year the company has not yet had.</p><p><br>The debate happens on a stone bench beside the Seine while wooden fuselages keep cracking into the river behind them. Investrix sees a duopoly regathering itself; Numerius sees olive-wood washers on a hull that loses its planking in flight.<br>Who&#39;s right when the entry price is $80–$100 and the market is at $224?</p><p><br>Topics: BA stock analysis, Boeing valuation, F-47 defence contract, Spirit AeroSystems reversal, 777X reach-forward charge, aerospace duopoly, PEG ratio mispricing</p>

Episode thumbnail for United Health (UNH): Is This Tax-Farming With Scrubs On?

April 22, 2026

United Health (UNH): Is This Tax-Farming With Scrubs On?

<p>Investrix presents UnitedHealth Group (UNH): fifty million members, $447 billion in revenue, $188 billion of pharmacy spend through one purchaser. A former CEO came back from retirement at seventy-three on a $1 salary and bought $25 million of his own stock on his first week in. The alignment signal is, Investrix argues, the clearest he has ever seen.</p><p><br />Numerius has concerns. Return on capital has halved in three years — from 15% to 8.5%. The guild dropped 1.2 to 1.3 million members from the Medicare rolls to make the math work. And 60% of every denarius collected comes through the Senate's pen — the same pen now holding a criminal investigation.</p><p><br />They walk the cheese stalls of Lutetia while Opportunus vanishes the moment insurance is mentioned. Investrix hears the bull case he wants to hear. Numerius sees a collegium publicanorum with medical clothes on.</p><p><br />Who's right? And what happens when Investrix, for once, refuses the trade not because the numbers fail — but because he understands what the eleven is?</p><p><br />Topics: UNH stock analysis, UnitedHealth Group valuation, Medicare Advantage risk, CMS rate cycle, medical care ratio, Stephen Hemsley insider buying, DOJ investigation</p>

13 total episodes available

Deep-dive analytics for Investrix and Numerius

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Investrix and Numerius?

A Gallic merchant walks into a Roman tavern with a stock tip. A Roman accountant reaches for his spectacles.

Every week, Investrix and Numerius — one optimist, one skeptic, both armed with real SEC filings and market data — debate a single publicly traded company over amphorae of Falernian wine.

The setting is ancient Rome. The analysis is modern. The arguments are genuine.

Investrix pitches growth stories with the passion of a man whose last grain cargo arrived mostly sand. Numerius dismantles them with bear-base-bull valuations and the patience of a man with five mouths to feed and exact

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Information about guest appearances is not available.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.